Protein Supplements to Cyclists

Haukeland University Hospital16 enrolled

Overview

To investigate the effect of marine peptide combined with dietary protein on the capacity to recover after exhaustive endurance cycling as measured by exercise capacity and blood glucose homeostasis.

The current study uses cyclists as test subjects since they represent a physical demanding sport requiring both high endurance capacity and muscle strength. In the recovery phase following exhaustive physical activity there is a need both for rebuilding the muscle energy stores, for muscle repair and for compensatory muscle cell development. Therefore, marine peptide combined with dietary protein will be given in order to examine the capacity to recover after exhaustive endurance cycling.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

SINGLE

Enrollment

Conditions

Reconstitution After Bicycle Intervention

Interventions

Active protein drinkDIETARY_SUPPLEMENT

Fish protein from cod to be used for man after Heavy excercise to restitute

Eligibility

Sex: MALEMin age: 40 YearsMax age: 50 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Signed informed Consent * The subject is a man between 40-50 years * The subject has a body mass index (BMI) between 19-29 * Willing to comply with all study procedures and be available for the length of the study * In good general health as judged by the physician at the screening visit Exclusion Criteria: * The subject has had surgery or trauma with significant blood loss or has donated blood within the last 3 months prior to the screening visit * Diabetes type 1 or 2, or persistent high blood sugar levels * The subject has tested positive for human immunodeficiency virus (HIV) * Hepatitis B surface antigen (HBsAg), or hepatitis C virus antibody (anti-HCV) * The subject has taken any investigational drugs within 1 month prior to screening * Treated with antibiotics within 3 months prior to screening (oral, parenteral or rectal), but not spray or ointment * Treated with steroids within 1 month prior to screening (including oral treatment) * Treated with medication that effects the intestinal function such as, H2- protonpump inhibitors, diuretics, antiemetics, antidepressants, antacids,

Locations (1)

Haukeland University Hospital

Bergen, Norway

RECRUITING

Outcomes

Primary Outcomes

Change in blood glucose compared to placebo

Time frame: Change from baseline to every 30 minutes after dosing, for 2 hours

Secondary Outcomes

Change in insulin-like peptide 5 compared to placebo

Time frame: Change from baseline to every 30 minutes after dosing, for 2 hours

Central Contacts

Trygve Hausken, MD

CONTACT

+4755972134 trygve.hausken@helse-bergen.no

Bente Frisk

CONTACT

+4755970440 bente.frisk@helse-bergen.no

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.